MOH vs. BNTX
MOH (Molina Healthcare, Inc.) and BNTX (BioNTech SE) are both stocks. Both are in the Healthcare sector — MOH in Healthcare Plans, BNTX in Biotechnology. Over the past 5 years, MOH returned -0.98%/yr vs -15.35%/yr for BNTX. At a 0.11 correlation, their price movements are largely independent.
Performance
MOH vs. BNTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MOH achieves a 39.96% return, which is significantly higher than BNTX's -5.39% return.
MOH
- 1D
- 4.10%
- 1M
- 21.27%
- 6M
- 33.58%
- YTD
- 39.96%
- 1Y
- 9.63%
- 3Y*
- -6.65%
- 5Y*
- -0.98%
- 10Y*
- 16.66%
BNTX
- 1D
- -1.55%
- 1M
- -0.52%
- 6M
- -11.85%
- YTD
- -5.39%
- 1Y
- -20.21%
- 3Y*
- -5.94%
- 5Y*
- -15.35%
- 10Y*
- —
MOH vs. BNTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MOH Molina Healthcare, Inc. | 39.96% | -40.37% | -19.45% | 9.41% | 3.82% | 49.56% | 56.74% | 20.26% |
BNTX BioNTech SE | -5.39% | -16.45% | 7.97% | -29.74% | -40.40% | 216.24% | 140.61% | 105.33% |
Correlation
The correlation between MOH and BNTX is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Oct 10, 2019 | 0.11 |
Fundamentals
MOH:
$12.65B
BNTX:
$22.78B
MOH:
$3.63
BNTX:
-€5.12
MOH:
0.28
BNTX:
6.94
MOH:
3.04
BNTX:
1.07
MOH:
$45.08B
BNTX:
€2.80B
MOH:
$2.80B
BNTX:
€2.05B
MOH:
$617.00M
BNTX:
-€815.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MOH vs. BNTX — Risk / Return Rank
MOH
BNTX
MOH vs. BNTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Molina Healthcare, Inc. (MOH) and BioNTech SE (BNTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MOH | BNTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.66 | ||
| Sortino ratioReturn per unit of downside risk | +1.03 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 0.94 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 0.22 | -0.68 | +0.90 |
| Martin ratioReturn relative to average drawdown | 0.40 | -1.27 | +1.67 |
Loading charts...
Drawdowns
MOH vs. BNTX - Drawdown Comparison
The maximum MOH drawdown since its inception was -70.76%, smaller than the maximum BNTX drawdown of -82.08%. Use the drawdown chart below to compare losses from any high point for MOH and BNTX.
Loading charts...
Drawdown Indicators
| MOH | BNTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.76% | -82.08% | +11.32% |
Max Drawdown (1Y)Largest decline over 1 year | -43.98% | -29.71% | -14.27% |
Max Drawdown (3Y)Largest decline over 3 years | -70.76% | -37.35% | -33.41% |
Max Drawdown (5Y)Largest decline over 5 years | -70.76% | -82.08% | +11.32% |
Max Drawdown (10Y)Largest decline over 10 years | -70.76% | — | — |
Current DrawdownCurrent decline from peak | -42.11% | -79.40% | +37.29% |
Average DrawdownAverage peak-to-trough decline | -24.68% | -56.50% | +31.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.94% | 15.96% | +8.98% |
Volatility
MOH vs. BNTX - Volatility Comparison
Molina Healthcare, Inc. (MOH) has a higher volatility of 11.57% compared to BioNTech SE (BNTX) at 9.13%. This indicates that MOH's price experiences larger fluctuations and is considered to be riskier than BNTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MOH | BNTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.57% | 9.13% | +2.44% |
Volatility (6M)Calculated over the trailing 6-month period | 44.26% | 34.74% | +9.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.49% | 41.53% | +14.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.16% | 54.91% | -14.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.91% | 75.99% | -35.08% |
Dividends
MOH vs. BNTX - Dividend Comparison
Neither MOH nor BNTX has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
BNTX BioNTech SE | 0.00% | 0.00% | 0.00% | 0.00% | 2.43% |
MOH Molina Healthcare, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MOH vs. BNTX - Financials Comparison
This section allows you to compare key financial metrics between Molina Healthcare, Inc. and BioNTech SE. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MOH and BNTX have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MOH has higher volatility (11.57%) compared to BNTX (9.13%). In terms of maximum drawdown, MOH dropped -70.76% vs BNTX's -82.08%.
MOH currently has the higher Sharpe Ratio (0.17 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MOH and BNTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer